Trial intelligence / Profile preview

Salbutamol, beclometasone, and ipratropium for prevention of pulmonary complications after CABG

IRCT2014052514359N2Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Aug 2014
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of salbutamol, beclomethasone and ipratropium bromide in postoperative respiratory complications (PRC), sponsored by Guilan University of Medical Sciences. Started Aug 2014; status: completed.

02

Drugs

salbutamolbeclomethasoneipratropium bromide
03

Conditions

postoperative respiratory complications (PRC)

Beyond the preview

Go deeper on IRCT2014052514359N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014052514359N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call